Bexarotene With Narrow-Band UVB for Psoriasis

NCT00151008 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Bexarotene/NBUVB vs placebo NBUVB

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]